Skip to main content

Table 2 Fasting lipids, lipoproteins and apolipoproteins in the three periods of treatment

From: Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report

 

(A) Diet

(B) Diet plus Fluvastatin 80 mg

(C) Diet plus Fluvastatin 80 mg plus Omacor 4 g

Total Cholesterolac

259 ± 55

174 ± 35

203 ± 54

LDL cholesterolac

157 ± 47

103 ± 25

127 ± 30

HDL cholesterolbc

34 ± 9

32 ± 10

40 ± 11

Non-HDL cholac

225 ± 55

142 ± 35

163 ± 54

Triglyceridesc

337 ± 153

263 ± 226

195 ± 129

VLDL triglyceridesc

289 ± 160

224 ± 222

136 ± 118

Tg/HDL-chol ratioc

4.80 ± 2.69

4.39 ± 5.10

2.23 ± 1.56

Apo A-1

113 ± 24

107 ± 41

124 ± 26

Apo B100ac

126 ± 34

89 ± 16

82 ± 16

Apo B48c

5.81 ± 2.59

4.12 ± 2.78

3.07 ± 1.47

Apo C-IIac

20.4 ± 6.1

18.1 ± 5.6

15.8 ± 6.8

Apo C-III a

18.7 ± 5.7

12.9 ± 3.5

12.8 ± 4.7

C-II/C-III ratio

1.13 ± 0.31

1.41 ± 0.29

1.30 ± 0.16

  1. Data showed as mg/dL except apo B48, in mg/L.
  2. a (A) vs (B) p < 0.05.
  3. b (B) vs (C) p < 0.05.
  4. c (A) vs (C) p < 0.05.